{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:33:01Z","timestamp":1793773981914,"version":"4.6.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ijbiomac.2022.10.117","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T03:18:27Z","timestamp":1666235907000},"page":"207-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Hyaluronic acid-coated proglycosomes for topical delivery of tofacitinib in rheumatoid arthritis condition: Formulation design, in vitro, ex vivo characterization, and in vivo efficacy studies"],"prefix":"10.1016","volume":"224","author":[{"given":"Srividya","family":"Gorantla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eswara Rao","family":"Puppala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.G.M.","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranendra N.","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Singhvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0005","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrd1109","article-title":"Therapeutic strategies for rheumatoid arthritis","volume":"2","author":"Smolen","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4155\/tde-2020-0029","article-title":"Targeted drug-delivery systems in the treatment of rheumatoid arthritis: recent advancement and clinical status","volume":"11","author":"Gorantla","year":"2020","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0015","unstructured":"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/musculoskeletal-conditios (accessed March 2, 2022)."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0020","unstructured":"Rheumatoid Arthritis | Concise Medical Knowledge, (n.d.). https:\/\/www.lecturio.com\/concepts\/rheumatoid-arthritis\/ (accessed March 2, 2022)."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0025","first-page":"3498","article-title":"JAK\/STAT pathway in pathology of rheumatoid arthritis (Review)","volume":"20","author":"Ciobanu","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMra1202117","article-title":"JAKs and STATs in immunity, immunodeficiency, and cancer","volume":"368","author":"O\u2019Shea","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0035","first-page":"278","article-title":"The Jak\/STAT pathway: a focus on pain in rheumatoid arthritis, semin","volume":"51","author":"Simon","year":"2021","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2021.119719","article-title":"Spectrophotometric method to quantify tofacitinib in lyotropic liquid crystalline nanoparticles and skin layers: application in ex vivo dermal distribution studies, spectrochim. Acta - part a Mol","volume":"255","author":"Gorantla","year":"2021","journal-title":"Biomol. Spectrosc."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0045","unstructured":"CHMP, Committee for Medicinal Products for Human Use (CHMP) Assessment report, 2017. www.ema.europa.eu\/contact (accessed June 15, 2020)."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0050","series-title":"Skin penetration and tissue permeation after topical administration of diclofenac","author":"Hagen","year":"2017"},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0055","series-title":"Revisiting techniques to evaluate drug permeation through skin","first-page":"1829","volume":"18","author":"Rapalli","year":"2021"},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0060","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1590\/s1984-82502016000300018","article-title":"52","author":"Ruela","year":"2016","journal-title":"Brazilian J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0065","first-page":"1","article-title":"Improved skin-permeated diclofenac-loaded lyotropic liquid crystal nanoparticles: QbD-driven industrial feasible process and assessment of skin deposition","author":"Waghule","year":"2020","journal-title":"Liq. Cryst."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.117053","article-title":"Exploring the affluent potential of glyceryl mono oleate \u2013 myristol liquid crystal nanoparticles mediated localized topical delivery of tofacitinib: study of systematic QbD, skin deposition and dermal pharmacokinetics assessment","volume":"346","author":"Gorantla","year":"2022","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119558","article-title":"Proposome for transdermal delivery of tofacitinib","volume":"585","author":"Kathuria","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120152","article-title":"Enhancing intradermal delivery of tofacitinib citrate: comparison between powder-loaded hollow microneedle arrays and dissolving microneedle arrays","volume":"593","author":"C\u00e1rcamo-Mart\u00ednez","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/nano8010042","article-title":"Lipid-based nanoparticles as a potential delivery approach in the treatment of rheumatoid arthritis","volume":"8","author":"Chuang","year":"2018","journal-title":"Nanomaterials."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0090","series-title":"Emerging trends in microneedle-based drug delivery strategies for the treatment of rheumatoid arthritis","first-page":"395","volume":"19","author":"Gorantla","year":"2022"},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0095","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.2147\/IJN.S138267","article-title":"Elastic liposomes as novel carriers: recent advances in drug delivery","volume":"12","author":"Hussain","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.colsurfb.2017.05.049","article-title":"Proglycosomes: a novel nano-vesicle for ocular delivery of tacrolimus","volume":"157","author":"Garg","year":"2017","journal-title":"Colloids Surf. B Biointerfaces."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0105","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1080\/17425247.2021.1950686","article-title":"CD44 receptor-targeted novel drug delivery strategies for rheumatoid arthritis therapy","volume":"18","author":"Gorantla","year":"2021","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0110","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1097-2765(04)00080-2","article-title":"Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44","volume":"13","author":"Teriete","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0115","series-title":"Biocompatible injectable polysaccharide materials for drug delivery","first-page":"127","author":"Cadinoiu","year":"2019"},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0120","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1016\/j.biomaterials.2012.05.026","article-title":"Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel","volume":"33","author":"Jain","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0125","unstructured":"Products | Sonics & Materials Inc., (n.d.). https:\/\/www.sonics.com\/vibracell\/products\/ (accessed September 17, 2022)."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116926","article-title":"Facile functionalization of teriflunomide-loaded nanoliposomes with chondroitin sulphate for the treatment of rheumatoid arthritis","volume":"250","author":"Mahtab","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43094-021-00325-0","article-title":"Design of experiment-driven stability-indicating RP-HPLC method for the determination of tofacitinib in nanoparticles and skin matrix","volume":"7","author":"Gorantla","year":"2021","journal-title":"Futur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120819","article-title":"Lithocholic acid-tryptophan conjugate (UniPR126) based mixed micelle as a nano carrier for specific delivery of niclosamide to prostate cancer via EphA2 receptor","volume":"605","author":"Jannu","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0145","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba2458","article-title":"H E a L T H a N D M E D I C I N E experimental and theoretical explorations of nanocarriers\u2019 multistep delivery performance for rational design and anticancer prediction","volume":"7","author":"Bao","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0150","unstructured":"VERSATILE APPLICATIONS *All dosage forms (leave on & rinse off) *Specific pharmaceutical red drums FCU26 (DMF): 25 Kg SEPINEO TM P 600 A key polymer for topical pharmaceutical innovation, (n.d.)."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0155","first-page":"1","article-title":"7","author":"Gorantla","year":"2021","journal-title":"Futur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0160","first-page":"1","article-title":"Dermatokinetic assessment of luliconazole-loaded nanostructured lipid carriers (NLCs) for topical delivery: QbD-driven design, optimization, and in vitro and ex vivo evaluations, drug deliv","author":"Mahmood","year":"2021","journal-title":"Transl. Res."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0165","first-page":"307","article-title":"Alginate: drug delivery and application","author":"Singhvi","year":"2020"},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0170","series-title":"Spreading of semisolid formulations: An update, Undefined","author":"Garg","year":"2002"},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111945","article-title":"Design and dermatokinetic evaluation of apremilast loaded nanostructured lipid carriers embedded gel for topical delivery: a potential approach for improved permeation and prolong skin deposition","volume":"206","author":"Rapalli","year":"2021","journal-title":"Colloids Surfaces B Biointerfaces."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0180","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijpharm.2015.12.061","article-title":"Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-\u03baB and FOXO1","volume":"499","author":"Garg","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0185","doi-asserted-by":"crossref","unstructured":"S. Jain, M.A. Mistry, N.K. Swarnakar, Enhanced dermal delivery of acyclovir using solid lipid nanoparticles, (n.d.). doi:10.1007\/s13346-011-0036-0.","DOI":"10.1007\/s13346-011-0036-0"},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0190","series-title":"Dermato-pharmacokinetic: assessment tools for topically applied dosage forms","first-page":"423","volume":"18","author":"Rapalli","year":"2020"},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0195","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ptr.5256","article-title":"Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models","volume":"29","author":"Parhiz","year":"2015","journal-title":"Phytother. Res."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0200","article-title":"Perillyl alcohol inhibits keratinocyte proliferation and attenuates imiquimod-induced psoriasis like skin-inflammation by modulating NF-\u03baB and STAT3 signaling pathways","volume":"103","author":"Yalamarthi","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154415","article-title":"Perillyl alcohol attenuates chronic restraint stress aggravated dextran sulfate sodium-induced ulcerative colitis by modulating TLR4\/NF-\u03baB and JAK2\/STAT3 signaling pathways","volume":"106","author":"Puppala","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.153926","article-title":"Perillyl alcohol attenuates rheumatoid arthritis via regulating TLR4\/NF-\u03baB and Keap1\/Nrf2 signaling pathways: A comprehensive study onin-vitro and in-vivo experimental models","volume":"97","author":"Puppala","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0215","doi-asserted-by":"crossref","first-page":"8830","DOI":"10.1021\/acsabm.0c01164","article-title":"Multifunctional synthetic amphiphile for niche therapeutic applications: mitigation of MRSA biofilms and potential in wound healing","volume":"3","author":"Dey","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0220","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0168-3659(02)00207-9","article-title":"Design of poly-epsilon-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery","volume":"83","author":"Barbault-Foucher","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0225","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jconrel.2013.11.016","article-title":"Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery","volume":"174","author":"Park","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0230","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.colsurfb.2018.08.061","article-title":"Hyaluronic acid-containing ethosomes as a potential carrier for transdermal drug delivery","volume":"172","author":"Xie","year":"2018","journal-title":"Colloids Surf. B. Biointerfaces."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0235","series-title":"Novel Long Retentive Posaconazole Ophthalmic Suspension","first-page":"4","author":"Simta","year":"2020"},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0240","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ijbiomac.2021.06.059","article-title":"Chitosan-based microneedles as a potential platform for drug delivery through the skin: trends and regulatory aspects","volume":"184","author":"Gorantla","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0245","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.colsurfb.2015.03.018","article-title":"Improved stability and skin permeability of sodium hyaluronate-chitosan multilayered liposomes by layer-by-layer electrostatic deposition for quercetin delivery","volume":"129","author":"Jeon","year":"2015","journal-title":"Colloids Surf. B Biointerfaces."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0250","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ijbiomac.2020.12.177","article-title":"Biodegradable microneedles fabricated with carbohydrates and proteins : revolutionary approach for transdermal drug delivery","volume":"170","author":"Dabholkar","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0255","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ijpharm.2013.06.052","article-title":"Selection of high efficient transdermal lipid vesicle for curcumin skin delivery","volume":"454","author":"Zhao","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0260","first-page":"278","article-title":"The Jak\/STAT pathway: a focus on pain in rheumatoid arthritis, semin","volume":"51","author":"Simon","year":"2021","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0265","doi-asserted-by":"crossref","first-page":"48","DOI":"10.7150\/thno.29715","article-title":"CD44 assists the topical anti-psoriatic efficacy of curcumin-loaded hyaluronan-modified ethosomes: a new strategy for clustering drug in inflammatory skin","volume":"9","author":"Zhang","year":"2019","journal-title":"Theranostics."},{"key":"10.1016\/j.ijbiomac.2022.10.117_bb0270","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2340\/00015555-1286","article-title":"Dermal distribution of hyaluronan in psoriatic arthritis; coexistence of CD44, MMP3 and MMP9","volume":"92","author":"Lindqvist","year":"2012","journal-title":"Acta Derm. Venereol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813022023637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813022023637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:46:00Z","timestamp":1758879960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813022023637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":54,"alternative-id":["S0141813022023637"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.10.117","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyaluronic acid-coated proglycosomes for topical delivery of tofacitinib in rheumatoid arthritis condition: Formulation design, in vitro, ex vivo characterization, and in vivo efficacy studies","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.10.117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}